SCHEMBL9285018

SCHEMBL9285018

O=P(O)(O)c1[nH]c(-c2ccccc2)c(-c2ccccc2)c1P(=O)(O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.42
ESR2 Q92731 4/20 0.42
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
PIM1 P11309 1/20 0.40
GFER P55789 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 2/20 0.38
PLA2G10 O15496 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA5A P35218 1/20 0.36
MDM2 Q00987 2/20 0.36
SERPINE1 P05121 1/20 0.35
PTGS2 P35354 3/20 0.35
HTT P42858 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1074359 0.70 NPSR1 (0.60) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL27979541 0.70 TYMP (0.40) KDM4EMAPTALDH1A1HPGDGAA
SCHEMBL15431517 0.68 CA2 (0.43) ESR1ESR2KDM4EMAPTALDH1A1
SCHEMBL3278733 0.68 ESR1 (0.62) ESR1ESR2KDM4EMAPTPIM1
SCHEMBL28677769 0.67 GPR84 (0.42) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL9736741 0.66 WEE1 (0.43) KDM4EMAPTTDP1CA2CA4
SCHEMBL3360427 0.63 KDM4E (0.40) KDM4EMAPTALDH1A1HPGDHSD17B10
Biphenyl SCHEMBL3763955 0.62 ALDH1A1 (0.60) ALDH1A1CA2CA4CA5AACP3
Biphenyl SCHEMBL3727875 0.62 ALDH1A1 (0.60) ALDH1A1CA2CA4CA5AACP3
Biphenyl SCHEMBL263925 0.62 ALDH1A1 (0.60) ALDH1A1CA2CA4CA5AACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0537008-B1 Use of biphosphonates for the manufacture of a medicament for blocking neoplastic transformation of cells induced by ras oncogenes SQUIBB & SONS INC (US) 1995-10-25 EP disclosed
EP-0537008-A1 Use of biphosphonates for the manufacture of a medicament for blocking neoplastic transformation of cells induced by ras oncogenes E.R. SQUIBB & SONS, INC. (US) 1993-04-14 EP disclosed
EP-0513760-A2 Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP disclosed